OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock - Currency: USD
Taking everything into account, OMI scores 4 out of 10 in our fundamental rating. OMI was compared to 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of OMI while its profitability can be described as average. OMI is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -7.53%, OMI is not doing good in the industry: 73.79% of the companies in the same industry are doing better.
With a Return On Equity value of -64.06%, OMI is not doing good in the industry: 73.79% of the companies in the same industry are doing better.
The Return On Invested Capital of OMI (7.06%) is better than 69.90% of its industry peers.
OMI had an Average Return On Invested Capital over the past 3 years of 6.37%. This is below the industry average of 9.71%.
The last Return On Invested Capital (7.06%) for OMI is above the 3 year average (6.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.53% | ||
| ROE | -64.06% | ||
| ROIC | 7.06% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
1.3 Margins
OMI's Operating Margin of 2.41% is in line compared to the rest of the industry. OMI outperforms 51.46% of its industry peers.
OMI's Operating Margin has improved in the last couple of years.
The Gross Margin of OMI (20.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of OMI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.41% | ||
| PM (TTM) | N/A | ||
| GM | 20.61% |
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OMI is destroying value.
OMI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OMI has more shares outstanding
Compared to 1 year ago, OMI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.53 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
OMI has a Altman-Z score (2.53) which is in line with its industry peers.
A Debt/Equity ratio of 3.32 is on the high side and indicates that OMI has dependencies on debt financing.
OMI has a worse Debt to Equity ratio (3.32) than 80.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.53 |
ROIC/WACC0.87
WACC8.1%
2.3 Liquidity
A Current Ratio of 1.13 indicates that OMI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, OMI is doing worse than 66.99% of the companies in the same industry.
A Quick Ratio of 0.41 indicates that OMI may have some problems paying its short term obligations.
The Quick ratio of OMI (0.41) is worse than 91.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
OMI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.00%.
OMI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.10% yearly.
The Revenue has been growing slightly by 2.84% in the past year.
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%
3.2 Future
Based on estimates for the next years, OMI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.25% on average per year.
Based on estimates for the next years, OMI will show a small growth in Revenue. The Revenue will grow by 2.98% on average per year.
EPS Next Y10.14%
EPS Next 2Y14.35%
EPS Next 3Y16.16%
EPS Next 5Y14.25%
Revenue Next Year2.74%
Revenue Next 2Y2.63%
Revenue Next 3Y2.77%
Revenue Next 5Y2.98%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.11, the valuation of OMI can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 98.06% of the companies listed in the same industry.
OMI is valuated cheaply when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 4.01 indicates a rather cheap valuation of OMI.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 99.03% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.58, OMI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.11 | ||
| Fwd PE | 4.01 |
4.2 Price Multiples
92.23% of the companies in the same industry are more expensive than OMI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.89 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OMI's earnings are expected to grow with 16.16% in the coming years.
PEG (NY)0.5
PEG (5Y)0.23
EPS Next 2Y14.35%
EPS Next 3Y16.16%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.97
-0.15 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.66%
Inst Owner Change0%
Ins Owners3.64%
Ins Owner Change19.58%
Market Cap610.58M
Analysts48.33
Price Target10.2 (27.98%)
Short Float %9.64%
Short Ratio5.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.75%
Min EPS beat(2)4.84%
Max EPS beat(2)16.66%
EPS beat(4)4
Avg EPS beat(4)7.71%
Min EPS beat(4)0.62%
Max EPS beat(4)16.66%
EPS beat(8)8
Avg EPS beat(8)7%
EPS beat(12)10
Avg EPS beat(12)15.12%
EPS beat(16)14
Avg EPS beat(16)15.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.28%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)0.52%
Revenue beat(8)2
Avg Revenue beat(8)-0.38%
Revenue beat(12)5
Avg Revenue beat(12)0.33%
Revenue beat(16)8
Avg Revenue beat(16)0.48%
PT rev (1m)0%
PT rev (3m)-11.66%
EPS NQ rev (1m)-4.53%
EPS NQ rev (3m)-18.19%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-5.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)-0.78%
Revenue NY rev (3m)0.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.11 | ||
| Fwd PE | 4.01 | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | 3.4 | ||
| P/B | 1.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.89 |
EPS(TTM)1.56
EY19.57%
EPS(NY)1.99
Fwd EY24.94%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)2.34
OCFY29.38%
SpS139.93
BVpS7.45
TBVpS-13.65
PEG (NY)0.5
PEG (5Y)0.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.53% | ||
| ROE | -64.06% | ||
| ROCE | 8.93% | ||
| ROIC | 7.06% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 16.76% | ||
| OM | 2.41% | ||
| PM (TTM) | N/A | ||
| GM | 20.61% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexcg growth 3Y-4.88%
ROICexcg growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score3
Asset Turnover2.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 96.66% | ||
| Cap/Sales | 2.27% | ||
| Interest Coverage | 1.72 | ||
| Cash Conversion | 35.14% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.41 | ||
| Altman-Z | 2.53 |
F-Score3
WACC8.1%
ROIC/WACC0.87
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
EPS Next Y10.14%
EPS Next 2Y14.35%
EPS Next 3Y16.16%
EPS Next 5Y14.25%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%
Revenue Next Year2.74%
Revenue Next 2Y2.63%
Revenue Next 3Y2.77%
Revenue Next 5Y2.98%
EBIT growth 1Y-16.96%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year97.3%
EBIT Next 3Y34.82%
EBIT Next 5YN/A
FCF growth 1Y-132.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.56%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%